The aptamer successfully targeted VEGF signaling in cisplatin-resistant cells via a nanoparticle chimera delivery system, which effectively knocked down the NOTCH3 gene for tumor regression in ovarian cancer 138. The gene discussed is NOTCH3; the disease is ovarian carcinoma.